GLN-TOPIRAMATE
Identification of Gln-Topiramate
| No description |
Google image searchProduct monograph
Active ingredient
topiramate, 200 MG
DIN: 02287781
Dosage form(s): TABLET
Route(s) of administration: ORAL
Schedule: Prescription
Company: GLENMARK PHARMACEUTICALS CANADA INC.
Date: 28-SEP-2021
ATC:
- N03 — ANTIEPILEPTICS (ATC, ATC/DDD, )
- N03A — ANTIEPILEPTICS (ATC, ATC/DDD)
- N03AX — Other antiepileptics (ATC, ATC/DDD)
- N03AX11 — TOPIRAMATE (ATC/DDD)
Reference brand drug: Topamax
Pharmaceutical standard: USP
